Viewing nowCombinationAmlokande Tablet 16/2.5 mg (Candesartan Cilexetil, Esamlodipine Besylate)
Candesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.

MFDS item code 202503323 · Approved 2025.12.19
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of Candesartan Cilexetil and Esamlodipine (Amlodipine). It effectively lowers blood pressure, reduces the risk of cardiovascular complications, and helps improve blood pressure management for patients.
The recommended dose is 1 tablet once daily, taken with water with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (candesartan cilexetil or S-amlodipine (amlodipine)). However, if blood pressure is not adequately controlled with monotherapy using the individual components, a direct switch to this medicine may be considered as follows. - 8/2.5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 milligrams or S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 16/2.5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams or S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 16/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams, S-amlodipine 5 milligrams (amlodipine 10 milligrams), or this medicine 16/2.5 milligrams. Patients taking candesartan cilexetil and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. • Patients with renal impairment: Since the recommended initial dose of candesartan cilexetil for patients with renal impairment is 4 milligrams once daily, it is not advisable to use this medicine as initial therapy. • Patients with hepatic impairment: Since the recommended initial dose of candesartan cilexetil for patients with mild or moderate hepatic impairment is 2 milligrams once daily, it is not advisable to use this medicine as initial therapy.
Adolescents and children 18 years of age or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.
This medication can cause serious damage to the fetus during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately once pregnancy is confirmed. This medication is contraindicated for certain patients. For example, individuals with allergies to the medication, pregnant women, patients with severe liver impairment, those with severe kidney impairment, or patients with a history of angioedema should not use it. Elderly patients or those with specific health conditions such as heart disease or kidney disease should exercise special caution when using this medication. While taking this medication, various side effects such as dizziness, headaches, swelling, dyspepsia, and skin rashes may occur, and if symptoms are severe, consultation with a healthcare provider is necessary. Interactions may occur when taking this medication with other antihypertensives, diuretics, or potassium-sparing diuretics, so inform your healthcare provider of any other medications you are taking. Pregnant or nursing women are advised not to take this medication, and nursing mothers should either discontinue breastfeeding or consider alternative treatments. Safety has not been established for children and adolescents under 18 years, so its use is not recommended. In the event of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur, and immediate consultation with a medical institution for appropriate treatment is needed. Store this medication out of reach of children, and do not transfer it into other containers. Caution is needed as dizziness may occur while driving a vehicle or operating machinery.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.
White, bi-convex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.